Tricol Biomedical
Manufacturing · Oregon, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
720 SW Washington St Ste 200, Portland, ...Phone Number
(503) 245-0459Website
www.tricolbiomedical.comRevenue
$12.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Tricol Biomedical
Tricol Biomedical is a medical device company focused on advancing hemostatic and wound care management through innovative products. Their offerings include solutions for trauma management, procedural care, and consumer self-care, utilizing their proprietary chitosan technology, Chito+. The company aims to prevent deaths due to blood loss by providing effective bleeding control products for both medical professionals and general consumers. Tricol partners with other medical device companies to enhance their hemostatic solutions, ensuring high-quality care in various settings.Explore more
Tricol Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tricol Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Tricol Biomedical had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Tricol Biomedical
Product Launch: Get notified when Tricol Biomedical launches new products
Funding: Get notified immidiatlly once Tricol Biomedical has new funding data
Tricol Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Tricol Biomedical recently announced quarterly report
Check out if Tricol Biomedical is spiking on competitors!
Check if Tricol Biomedical has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Tricol Biomedical
Find 3 more new buyers
Compare Similar Companies to Tricol Biomedical
Compare insights from companies similar to Tricol Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7.1M
11-50
Private
-
-
JR
Janet RemmelManager, Human Resources & Chief Financial Officer & Executive Assistant
Company Profile Activity
Activity Insights
Tricol Biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tricol Biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tricol Biomedical.
Tricol Biomedical financials insights
Gather financial insights about Tricol Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Private Equity
$12M
2020
Debt
$150K
Tricol Biomedical Tech Stack
A closer look at the technologies used by Tricol Biomedical
See more technologies
Tricol Biomedical News & Media
Tricol Biomedical Expands Product Lines with Group Purchasing Organizations Premier and Vizient; Salvin Dental Specialties Is Now Tricol’s Exclusive U.S. Dental Distributor
New Product Offerings with Strategic Partners Will Expand Access for End Users OneStop(TM) Vascular Premier and Vizient GPO agreements will now include the OneStop™ Vascular line (1.5 in, 2 in, and pre-slit) to provide unique, non-invasive solutions to control bleeding quickly and safely in both planned and emergent medical procedures. HemCon Dental Dressing Pro Tricol’s agreement with Salvin Dental Specialties enables the distributor to sell – exclusively – Tricol’s HemCon® Dental Dressing PROPreclinical Evaluation of Tricol Biomedical’s Absorbable Biocompatible Chitosan (ABC) Wound Dressing Demonstrates Bioabsorption and Biocompatability in Internal Bleeding
The poster presentation at the Military Health System Research Symposium investigated the use of the ABC compound in an animal study. The poster presentation at the Military Health System Research Symposium investigated the use of the ABC compound in an animal study.Tricol Biomedical Receives NIH Phase IIB Grant to Continue Development of its Hemostatic Device for the Prostate
Portland, OR, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Tricol Biomedical, a privately held medical device company dedicated to saving lives through innovative hemostatic and wound care solutions, has received an $853,585 grant from the National Institute Of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health’s Small Business Technology Transfer (STTR) Program. The Phase IIB grant will support final development of Tricol’s proprietary hemostatic device to address bleeding inTricol Biomedical launches sales and marketing agency agreement with NorthStar Sales Alliance
Agreement with NorthStar aims to increase hemostatic portfolio in healthcare alternate sites in US. Agreement with NorthStar aims to increase hemostatic portfolio in healthcare alternate sites in US.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tricol Biomedical
Sign Up For FreeTo access detailed company insights
Tricol Biomedical is a medical device company focused on advancing hemostatic and wound care management through innovative products. Their offerings include solutions for trauma management, procedural care, and consumer self-care, utilizing their proprietary chitosan technology, Chito+. The company aims to prevent deaths due to blood loss by provid... Read More
